1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Medical Simulation Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product and Services
6.1 Model-based Simulation
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Surgical Simulation
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Ultrasound Simulation
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Web-based Simulation
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Simulation Training Services
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Fidelity
7.1 Low Fidelity
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Medium Fidelity
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 High Fidelity
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Academic Institutions and Research Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Military Organizations
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Cardionics Inc. (3B Scientific GmbH)
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Gaumard Scientific Company Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Kyoto Kagaku Co. Ltd
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Laerdal Medical
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 Mentice
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Operative Experience Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Simbionix USA Corporation (3D Systems)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Simulab Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Surgical Science Sweden AB
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Synaptive Medical Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 SynBone AG
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 VirtaMed AG
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer